RTTNews | Sep 22, 2020 08:35AM EDT

08:34 Tuesday, September 22, 2020 (RTTNews) - DURECT Announces Study Design For Phase 2b AHFIRM Clinical Trial Of DUR-928 In Severe AH Patients

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved